LOS ANGELES--(BUSINESS WIRE)--
Lion Biotechnologies, Inc. (OTCQB: LBIO) announced that Chief Executive
Officer Manish Singh, Ph.D., will present at the Biotech Showcase on
Wednesday, January 15, 2014, at 11:00 a.m. Pacific. The conference is
being held at the Parc 55 Wyndham Union Square Hotel in San Francisco.
Dr. Singh’s presentation will be in Mission Room II.
Now in its sixth year, Biotech Showcase is an investor and partnering
conference devoted to providing private and public biotechnology and
life sciences companies with an opportunity to present to, and meet
with, investors and pharmaceutical executives in one place. This rapidly
growing conference features multiple tracks of presenting companies,
plenary sessions, workshops, networking, and an opportunity to schedule
A live webcast of the presentation will be accessible online on at www.lionbio.com.
An archived version will be available for 90 days following the event.
About Lion Biotechnologies
Lion Biotechnologies, Inc. is engaged in the development of T-cells and
engineered T-cells for the treatment of various cancers. The company's
lead product candidate is a ready-to-infuse autologous T-cell therapy
utilizing tumor-infiltrating lymphocytes (TILs) for the treatment of
patients with Stage IV metastatic melanoma, and is based on a clinical
CRADA with the National Cancer Institute along with physician-sponsored
investigational therapy at the MD Anderson Cancer Center and the H. Lee
Moffitt Cancer & Research Institute. For more information, please visit http://www.lionbio.com.
Source: Lion Biotechnologies, Inc.